Allogeneic Umbilical Cord Blood Therapy for Stroke

Completed

Phase 1 Results N/A

Summary of Purpose

This open label trial is conducted to investigate the efficacy and safety of allogeneic umbilical cord blood (UCB) therapy for patients with stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 October 2017.

1 Jun 2013 19 Jun 2013 1 May 2015 1 Dec 2015 1 Oct 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment

Contacts